Financial and Investment Analysts H-1B salary at APNAR PHARMA LLP: $82,500 average ($82,500-$82,500 range). 50% approval rate.
APNAR PHARMA LLP has sponsored 2 H-1B petitions for Financial and Investment Analysts roles. The average offered salary of $83k is 0% above the prevailing wage for this occupation. Most positions are located in California (100%). The certification rate is 50%. 50% of these filings are for new employment.
| Total Filings | 2 |
| Approval Rate | 50% |
| Average Salary | $82,500 |
| Median Salary | $82,500 |
| 25th Percentile | $82,500 |
| 75th Percentile | $82,500 |
| Minimum Salary | $82,500 |
| Maximum Salary | $82,500 |
100% of filings offer salaries above the prevailing wage, with an average premium of 0.3%. The average prevailing wage is $82k (based on 2 filings with prevailing wage data).
Average processing time is 9 days (median: 12 days). Fastest: 6 days, slowest: 12 days. Based on 2 filings.
50% of filings are for new positions, while 0% are for continued employment (2 filings with data).
Average contract duration: 36 months (median: 36 months), based on 2 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 2 |
| State | Filings |
|---|---|
| California | 2 |
APNAR PHARMA LLP has 2 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at APNAR PHARMA LLP is $82,500, with a median of $82,500. Salaries range from $82,500 to $82,500.
The H-1B approval rate for Financial and Investment Analysts positions at APNAR PHARMA LLP is 50% based on 2 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.